Pulmonary uptake of sufentanil during and after constant rate infusion

British Journal of Anaesthesia

Volumn 76, Issue 2, 1996, Pages 203-208

  Boer, F ^a   Olofsen, E ^a   Bovill, J G ^a   Burm, A G L ^a   Hak, A ^a   Geerts, M ^a   Wetselaar, K E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Analgesic techniques, infusion; Analgesics opioid, sulfentanil; Lung, metabolic function; Pharmacokinetics, sulfentanil

Indexed keywords

ENFLURANE; NARCOTIC ANALGESIC AGENT; SUFENTANIL;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; DRUG DISTRIBUTION; DRUG UPTAKE; ELECTIVE SURGERY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG; PRIORITY JOURNAL; PULMONARY ARTERY; RADIAL ARTERY; SMOKING;

EID: 0030051320     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/76.2.203     Document Type: Article

References (16)

1. Boer F, Bovill JG, Burm AGL, Mooren RAG. Uptake of sufentanil, alfeatanil and morphine in the lungs of patients about to undergo coronary artery surgery. British Journal of Anaesthesia 1992; 68: 370-375.
2. Upton RN, Mather LE, Runciman WB, Nancarrow C, Carapetis RJ. The use of mass balance principles to describe regional drug distribution and elimination. Journal of Pharmacokinetics and Biopharmaceutics 1988; 16: 13-29.
3. Yelderman ML. Continuous measurement of cardiac output with the use of stochastic system identification techniques. Journal of Clinical Monitoring 1990; 6: 322-332.
4. Yelderman ML, Ramsay MA, Quinn MD, Paulsen AW, McKown RC, Gillman PH. Continuous thermodilution cardiac output measurement in intensive care patients. Journal of Cardiothoracic and Vascular Anesthesia 1992; 6: 270-274.
5. Gilbert HC, Vender JS, Myers P. Evaluation of continuous cardiac output in patients undergoing coronary artery bypass surgery. Anesthesiology 1992; 77: A472.
6. Davis RF, Sakuma G. Comparison of semi-continuous thermodilution to intermittent bolus thermodilution cardiac output determinations. Anesthesiology 1992; 77: A477.
7. Gerlowski LE, Jain RK. Physiological based pharmacokinetic modelling: principles and applications. Journal of Pharmaceutical Sciences 1983; 72: 1103-1127.
8. Taeger K, Weninger E, Schmelzer F, Adt M, Franke N, Peter K. Pulmonary kinetics of fentanyl and alfentanil in surgical patients. British Journal of Anaesthesia 1988; 61: 425-434.
9. Upton RN, Runciman WB, Mather LE, McLean CF, Ilsley AH. The uptake and elution of lignocaine and procainamide in the hindquarters of the sheep described using mass balance principles. Journal of Pharmacokinetics and Biopharmaceutics 1988; 16: 31-40.
10. Boer F, Engbers FHM, Bovill JG, Burm AGL, Hak A. Sufentanil first-pass pulmonary uptake at three different steady state concentrations of the drug. British Journal of Anaesthesia 1995; 74: 50-55.
11. Bahkle YS, Hartiala J, Toivonen H, Uotila P. Effects of cigarette smoke on the metabolism of vasoactive hormones in rat isolated lungs. British Journal of Pharmacology 1979; 65: 495-499.
12. Kitamura S. Effects of cigarette smoking on metabolic events in the lungs. Environmental and Health Perspectives 1987; 72: 283-296.
13. Hoidal JR, Niewoehner DE. Lung phagocyte recruitment and metabolic alterations induced by cigarette smoke in humans and in hamsters. American Review of Respiratory Disease 1982; 126: 548-552.
14. Harris JO, Swenson EW, Johnson JE. Human alveolar macrophages: comparison of phagocyte ability, glucose utilization., and ultrastructure in smokers and nonsmokers. Journal of Clinical Investigation 1970; 49: 2086-2096.
15. Davies P, Sornberger GC, Huber GL. The stereology of pulmonary alveolar macrophages after prolonged experimental exposure to tobacco smoke. Laboratory Investigation 1977; 37: 297-306.
16. MacIntyre AC, Cutler DJ. The potential role of lysosomes in tissue distribution of weak bases. Biopharmaceutics and Drug Disposition 1988; 9: 513-526.